dipyridamole has been researched along with Apnea in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Apnea: A transient absence of spontaneous respiration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ottervanger, JP | 1 |
| Haan, D | 1 |
| Gans, SJ | 1 |
| Hoorntje, JC | 1 |
| Stricker, BH | 1 |
1 other study available for dipyridamole and Apnea
| Article | Year |
|---|---|
[Bronchospasm, apnea and heart arrest following dipyridamole perfusion scintigraphy].
Topics: Aged; Apnea; Bronchial Spasm; Dipyridamole; Heart Arrest; Humans; Lung Diseases, Obstructive; Male | 1993 |